A detailed history of Affinity Asset Advisors, LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 1,400,000 shares of WVE stock, worth $16.8 Million. This represents 1.98% of its overall portfolio holdings.

Number of Shares
1,400,000
Previous 375,000 273.33%
Holding current value
$16.8 Million
Previous $1.87 Million 513.52%
% of portfolio
1.98%
Previous 0.25%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.12 - $9.01 $5.25 Million - $9.24 Million
1,025,000 Added 273.33%
1,400,000 $11.5 Million
Q2 2024

Aug 14, 2024

BUY
$4.38 - $6.48 $387,257 - $572,929
88,415 Added 30.85%
375,000 $1.87 Million
Q1 2024

May 14, 2024

BUY
$3.54 - $6.84 $1.01 Million - $1.96 Million
286,585 New
286,585 $1.77 Million

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.04B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.